DWD 81.06(5)(b)1.c. c. Maximum treatment is 4 injections to any one site.
DWD 81.06(5)(b)2. 2. All of the following guidelines apply to sacroiliac joint injections:
DWD 81.06(5)(b)2.a. a. Time for treatment response is within one week.
DWD 81.06(5)(b)2.b. b. Maximum treatment frequency may permit repeat injection 2 weeks after the previous injection if there is a positive response to the first injection. Only 2 injections per patient visit.
DWD 81.06(5)(b)2.c. c. Maximum treatment is 2 injections to any one site.
DWD 81.06(5)(b)3. 3. All of the following guidelines apply to facet joint or nerve injections:
DWD 81.06(5)(b)3.a. a. Time for treatment response is within one week.
DWD 81.06(5)(b)3.b. b. Maximum treatment frequency is once every 2 weeks to any one site if there is a positive response to the first injection. If subsequent injections demonstrate diminishing control of symptoms or fail to facilitate objective functional gains, then injections shall be discontinued. Only 3 injections to different sites per patient visit.
DWD 81.06(5)(b)3.c. c. Maximum treatment is 3 injections to any one site.
DWD 81.06(5)(b)4. 4. All of the following guidelines apply to nerve root blocks:
DWD 81.06(5)(b)4.a. a. Time for treatment response is within one week.
DWD 81.06(5)(b)4.b. b. Maximum treatment frequency may permit repeat injection 2 weeks after the previous injection if there is a positive response to the first injection. Only 3 injections to different sites per patient visit.
DWD 81.06(5)(b)4.c. c. Maximum treatment is 2 injections to any one site. Maximum treatment is 2 injections to any one site.
DWD 81.06(5)(b)5. 5. All of the following guidelines apply to epidural injections:
DWD 81.06(5)(b)5.a. a. Time for treatment response is within one week.
DWD 81.06(5)(b)5.b. b. Maximum treatment frequency is once every 2 weeks if there is a positive response to the first injection. If subsequent injections demonstrate diminishing control of symptoms or fail to facilitate objective functional gains, then injections should be discontinued. Only one injection per patient visit.
DWD 81.06(5)(b)5.c. c. Maximum treatment is 3 injections.
DWD 81.06(5)(c) (c) For purposes of this paragraph, “lytic or sclerosing injections" include radio frequency denervation of the facet joints. These injections may only be given in conjunction with active treatment modalities directed to the same anatomical site. All of the following guidelines apply to lytic or sclerosing injections:
DWD 81.06(5)(c)1. 1. Time for treatment response is up to 6 weeks.
DWD 81.06(5)(c)2. 2. Maximum treatment frequency may repeat 4 times per year or once every 3 months for any site.
DWD 81.06(5)(c)3. 3. Maximum of 2 injections to any one site.
DWD 81.06(5)(d) (d) Prolotherapy and botulinum toxin injections are not necessary in the treatment of low back problems.
DWD 81.06(6) (6)Surgery, including decompression procedures and arthrodesis.
DWD 81.06(6)(a)(a) A health care provider may only perform surgery if it meets the specific guidelines specified in subs. (11), (12), (13), and s. DWD 81.12 (1).
DWD 81.06(6)(b) (b) In order to optimize the beneficial effect of surgery, postoperative therapy with active and passive treatment modalities may be provided, even if these modalities had been used in the preoperative treatment of the condition. In the postoperative period, the maximum treatment duration with passive treatment modalities in a clinical setting from the initiation of the first passive modality used, except bedrest or bracing, is as follows:
DWD 81.06(6)(b)1. 1. Eight weeks following lumbar decompression or implantation of a spinal cord stimulator or intrathecal drug delivery system.
DWD 81.06(6)(b)2. 2. Twelve weeks following arthrodesis.
DWD 81.06(6)(c) (c) Repeat surgery shall also meet the guidelines of subs. (11), (12), (13), and s. DWD 81.12 (1).
DWD 81.06(6)(d) (d) The surgical therapies in subds. 1. and 2. have very limited application and require a personality or psychosocial evaluation that indicates the patient is likely to benefit from the treatment:
DWD 81.06(6)(d)1. 1. Spinal cord stimulator may be necessary for a patient who has neuropathic pain and has had a favorable response to a trial screening period.
DWD 81.06(6)(d)2. 2. Intrathecal drug delivery system may be necessary for a patient who has somatic or neuropathic pain and has had a favorable response to a trial screening period.
DWD 81.06(7) (7)Chronic management. Chronic management of low back pain shall be provided according to the guidelines of s. DWD 81.13.
DWD 81.06(8) (8)Durable medical equipment.
DWD 81.06(8)(a)(a) A health care provider may direct the use of durable medical equipment in any of the following:
DWD 81.06(8)(a)1. 1. Lumbar braces, corsets, or supports are necessary within the guidelines of sub. (3) (k).
DWD 81.06(8)(a)2. 2. For patients using electrical muscle stimulation or mechanical traction devices at home, the device and any required supplies are necessary within the guidelines of sub. (3) (e) and (f).
DWD 81.06(8)(a)3. 3. Exercise equipment for home use, including bicycles, treadmills, and stairclimbers, are necessary only as part of an approved chronic management program. This equipment is not necessary during initial nonsurgical care or during reevaluation and surgical therapy. If the employer has an appropriate exercise facility on its premises with the prescribed equipment, the insurer may mandate use of that facility instead of authorizing purchase of the equipment for home use.
DWD 81.06(8)(a)3.a. a. `Indications.' The patient is deconditioned and requires reconditioning that may be accomplished only with the use of the prescribed exercise equipment. A health care provider shall document specific reasons why the exercise equipment is necessary and may not be replaced with other activities.
DWD 81.06(8)(a)3.b. b. `Requirements.' The use of the equipment shall have specific goals and there shall be a specific set of prescribed activities.
DWD 81.06(8)(b) (b) All of the following durable medical equipment is not necessary for home use for low back conditions:
DWD 81.06(8)(b)1. 1. Whirlpools, Jacuzzis, hot tubs, and special bath or shower attachments.
DWD 81.06(8)(b)2. 2. Beds, waterbeds, mattresses, chairs, recliners, and loungers.
DWD 81.06(9) (9)Evaluation of treatment by health care provider.
DWD 81.06(9)(a)(a) A health care provider shall evaluate at each visit whether the treatment is medically necessary and shall evaluate whether initial nonsurgical treatment is effective according to pars. (b) to (e). No later than the time for treatment response established for the specific modality in subs. (3) to (5), a health care provider shall evaluate whether the passive, active, injection, or medication treatment modality is resulting in progressive improvement in pars. (b) to (e).
DWD 81.06(9)(b) (b) The patient's subjective complaints of pain or disability are progressively improving, as evidenced by documentation in the medical record of decreased distribution, frequency, or intensity of symptoms.
DWD 81.06(9)(c) (c) The objective clinical findings are progressively improving, as evidenced by documentation in the medical record of resolution or objectively measured improvement in physical signs of the injury.
DWD 81.06(9)(d) (d) The patient's functional status, especially vocational activity, is progressively improving, as evidenced by documentation in the medical record or documentation of work ability involving less restrictive limitations on activity.
DWD 81.06(9)(e) (e) If there is not progressive improvement in at least 2 criteria specified in pars. (b) to (d), the modality shall be discontinued or significantly modified or a health care provider shall reconsider the diagnosis. The evaluation of the effectiveness of the treatment modality may be delegated to another health care provider.
DWD 81.06(10) (10)Medication management.
DWD 81.06(10)(a)(a) Prescription of controlled substance medications under ch. 450, Stats., including opioids and narcotics, are indicated primarily for the treatment of severe acute pain. These medications are not recommended in the treatment of patients with persistent low back pain.
DWD 81.06(10)(b) (b) Patients with radicular pain may require longer periods of treatment.
DWD 81.06(10)(c) (c) A health care provider shall document the rationale for the use of any scheduled medication. Treatment with nonnarcotic medication may be appropriate during any phase of treatment and intermittently after all other treatment has been discontinued. The prescribing health care provider shall determine that ongoing medication is effective treatment for the patient's condition.
DWD 81.06(11) (11)Specific treatment guidelines for regional low back pain.
DWD 81.06(11)(a)(a) A health care provider shall use initial nonsurgical treatment as the first phase of treatment for all patients with regional low back pain under sub. (1) (b) 1.
DWD 81.06(11)(a)1. 1. The passive, active, injection, durable medical equipment, and medication treatment modalities and procedures in subs. (3), (4), (5), (8), and (10) may be used in sequence or simultaneously during the period of initial nonsurgical management, depending on the severity of the condition.
DWD 81.06(11)(a)2. 2. The only therapeutic injections necessary for patients with regional low back pain are trigger point injections, facet joint injections, facet nerve injections, sacroiliac joint injections, and epidural blocks, and their use shall meet the guidelines of sub. (5).
DWD 81.06(11)(a)3. 3. After the first week of treatment, initial nonsurgical treatment shall at all times contain active treatment modalities according to the guidelines in sub. (4).
DWD 81.06(11)(a)4. 4. Initial nonsurgical treatment shall be provided in the least intensive setting consistent with quality health care practices.
DWD 81.06(11)(a)5. 5. Except as otherwise specified in sub. (3), passive treatment modalities in a clinic setting or requiring attendance by a health care provider are not necessary beyond 12 weeks after any passive modality other than bedrest or bracing is first initiated.
DWD 81.06(11)(b) (b) Surgical evaluation or chronic management is necessary if the patient continues with symptoms and physical findings after the course of initial nonsurgical care and if the patient's condition prevents the resumption of the regular activities of daily life, including regular vocational activities. The purpose of surgical evaluation is to determine whether surgery is necessary in the treatment of a patient who has failed to recover with initial nonsurgical care. If the patient is not a surgical candidate, then chronic management is necessary.
DWD 81.06(11)(b)1. 1. Surgical evaluation, if necessary, may begin as soon as 8 weeks after, but shall begin no later than 12 weeks after, beginning initial nonsurgical management. An initial recommendation or decision against surgery may not preclude surgery at a later date.
DWD 81.06(11)(b)2. 2. Surgical evaluation may include the use of appropriate medical imaging techniques. The imaging technique shall be chosen on the basis of the suspected etiology of the patient's condition but a health care provider shall follow the guidelines in s. DWD 81.05. Medical imaging studies that do not meet these guidelines are not necessary.
DWD 81.06(11)(b)3. 3. Surgical evaluation may also include diagnostic blocks and injections. These blocks and injections are only necessary if their use is consistent with the guidelines of sub. (1) (j).
DWD 81.06(11)(b)4. 4. Surgical evaluation may also include personality or psychosocial evaluation, consistent with the guidelines of sub. (1) (i).
DWD 81.06(11)(b)5. 5. Consultation with other health care providers may be appropriate as part of the surgical evaluation. The need for consultation and the choice of consultant will be determined by the findings on medical imaging, diagnostic analgesic blocks, and injections, if performed, and the patient's ongoing subjective complaints and physical findings.
DWD 81.06(11)(b)6. 6. The only surgical procedures necessary for patients with regional low back pain are decompression of a lumbar nerve root or lumbar arthrodesis, with or without instrumentation, which shall meet the guidelines of sub. (6) and s. DWD 81.12 (1). For patients with failed back surgery, spinal cord stimulators or intrathecal drug delivery systems may be necessary and consistent with sub. (6) (d).
DWD 81.06(11)(b)6.a. a. If surgery is necessary, it shall be offered to the patient as soon as possible. If the patient agrees to the proposed surgery, it shall be performed as expeditiously as possible consistent with sound medical practice.
DWD 81.06(11)(b)6.b. b. If surgery is not necessary, or if the patient does not wish to proceed with surgery, then the patient is a candidate for chronic management under the guidelines in s. DWD 81.13.
DWD 81.06(11)(c) (c) If the patient continues with symptoms and objective physical findings after surgical therapy has been rendered or the patient refuses surgical therapy or the patient was not a candidate for surgical therapy, and if the patient's condition prevents the resumption of the regular activities of daily life including regular vocational activities, then the patient may be a candidate for chronic management that shall be provided under the guidelines in s. DWD 81.13.
DWD 81.06(12) (12)Specific treatment guidelines for radicular pain, with or without regional low back pain, with no or static neurologic deficits.
DWD 81.06(12)(a)(a) Initial nonsurgical treatment is appropriate for all patients with radicular pain, with or without regional low back pain, with no or static neurologic deficits under sub. (1) (b) 2., and shall be the first phase of treatment. It shall be provided within the guidelines of sub. (11) (a), with the following modifications: Epidural blocks and nerve root and peripheral nerve blocks are the only therapeutic injections necessary for patients with radicular pain only. If there is a component of regional low back pain, therapeutic facet joint injections, facet nerve injections, trigger point injections, and sacroiliac injections may also be necessary.
DWD 81.06(12)(b) (b) Surgical evaluation or chronic management is necessary if the patient continues with symptoms and physical findings after the course of initial nonsurgical care and if the patient's condition prevents the resumption of the regular activities of daily life, including regular vocational activities. It shall be provided within the guidelines of sub. (11) (b).
DWD 81.06(12)(c) (c) If the patient continues with symptoms and objective physical findings after surgical therapy has been rendered or the patient refused surgical therapy or the patient was not a candidate for surgical therapy, and if the patient's condition prevents the resumption of the regular activities of daily life including regular vocational activities, then the patient may be a candidate for chronic management. Any course or program of chronic management for patients with radicular pain, with or without regional low back pain, with static neurologic deficits shall be provided under the guidelines of s. DWD 81.13.
DWD 81.06(13) (13)Specific treatment guidelines for cauda equina syndrome and for radicular pain, with or without regional low back pain, with progressive neurologic deficits.
DWD 81.06(13)(a)(a) Patients with cauda equina syndrome or with radicular pain, with or without regional low back pain, with progressive neurologic deficits may require immediate or emergency surgical evaluation at any time during the course of the overall treatment. The decision to proceed with surgical evaluation is made by a health care provider based on the type of neurologic changes observed, the severity of the changes, the rate of progression of the changes, and the response to any initial nonsurgical treatments. Surgery, if necessary, may be performed at any time during the course of treatment. Surgical evaluation and surgery shall be provided within the guidelines of sub. (11) (b), except that surgical evaluation and surgical therapy may begin at any time.
DWD 81.06(13)(b) (b) If a health care provider decides to proceed with a course of initial nonsurgical care for a patient with radicular pain with progressive neurologic changes, it shall follow the guidelines of sub. (12) (a).
DWD 81.06(13)(c) (c) If the patient continues with symptoms and objective physical findings after surgical therapy has been rendered or the patient refuses surgical therapy or the patient was not a candidate for surgical therapy, and if the patient's condition prevents the resumption of the regular activities of daily life including regular vocational activities, then the patient may be a candidate for chronic management. Any course or program of chronic management for patients with radicular pain, with or without regional low back pain, with foot drop or progressive neurologic changes at first presentation shall be provided under the guidelines of s. DWD 81.13.
DWD 81.06 History History: CR 07-019: cr. Register October 2007 No. 622, eff. 11-1-07.
DWD 81.07 DWD 81.07Neck pain.
DWD 81.07(1) (1)Diagnostic procedures for treatment of neck injury.
DWD 81.07(1)(a)(a) A health care provider shall determine the nature of the neck condition before initiating treatment.
DWD 81.07(1)(b) (b) A health care provider shall perform and document an appropriate history and physical examination. Based on the history and physical examination the health care provider shall assign the patient at each visit to the appropriate clinical category in subds. 1. to 4. A health care provider shall document the diagnosis in the medical record. For the purposes of subds. 2. and 3., “radicular pain" means pain radiating distal to the shoulder. This section does not apply to fractures of the cervical spine or cervical pain due to an infectious, immunologic, metabolic, endocrine, neurologic, visceral, or neoplastic disease process.
DWD 81.07(1)(b)1. 1. Regional neck pain includes referred pain to the shoulder and upper back. Regional neck pain includes the diagnoses of cervical strain, sprain, myofascial syndrome, musculoligamentous injury, soft tissue injury, and other diagnoses for pain believed to originate in the discs, ligaments, muscles, or other soft tissues of the cervical spine and that affects the cervical region, with or without referral to the upper back or shoulder, including ICD-9-CM codes 720 to 720.9, 721 to 721.0, 721.5 to 721.90, 722.3 to 722.30, 722.4, 722.6, 722.9 to 722.91, 723 to 723.3, 723.5 to 723.9, 724.5, 724.8, 724.9, 732.0, 737 to 737.9, 738.4, 738.5, 739.1, 756.1 to 756.19, 847 to 847.0, 920, 922.3, 925, and 926.1 to 926.12.
DWD 81.07(1)(b)2. 2. Radicular pain, with or without regional neck pain, with no or static neurologic deficit includes the diagnoses of brachialgia, cervical radiculopathy, radiculitis, or neuritis; displacement or herniation of intervertebral disc with radiculopathy, radiculitis, or neuritis; spinal stenosis with radiculopathy, radiculitis, or neuritis; and other diagnoses for pain in the arm distal to the shoulder believed to originate with irritation of a nerve root in the cervical spine, including ICD-9-CM codes 721.1, 721.91, 722 to 722.0, 722.2, 722.7 to 722.71, 723.4, and 724 to 724.00. In these cases neurologic findings on history and examination are either absent or do not show progressive deterioration.
DWD 81.07(1)(b)3. 3. Radicular pain, with or without regional neck pain, with progressive neurologic deficit, includes the same diagnoses as subd. 2., except in these cases there is a history of progressive deterioration in the neurologic symptoms and physical findings, including worsening sensory loss, increasing muscle weakness, and progressive reflex changes.
DWD 81.07(1)(b)4. 4. Cervical compressive myelopathy, with or without radicular pain, is a condition characterized by weakness and spasticity in one or both legs and associated with any of the following: exaggerated reflexes, an extensor plantar response, bowel or bladder dysfunction, sensory ataxia, or bilateral sensory changes.
DWD 81.07(1)(c) (c) A health care provider may not order laboratory tests in the evaluation of a patient with regional neck pain, or radicular pain, except for any of the following:
DWD 81.07(1)(c)1. 1. When a patient's history, age, or examination suggests infection, metabolic-endocrinologic disorders, tumorous conditions, or systemic musculoskeletal disorders, such as rheumatoid arthritis or ankylosing spondylitis.
DWD 81.07(1)(c)2. 2. To evaluate potential adverse side effects of medications.
Loading...
Loading...
Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each page is the date the chapter was last published.